IL144529A0 - Meiosis activating sterol augments implantation rate - Google Patents

Meiosis activating sterol augments implantation rate

Info

Publication number
IL144529A0
IL144529A0 IL14452900A IL14452900A IL144529A0 IL 144529 A0 IL144529 A0 IL 144529A0 IL 14452900 A IL14452900 A IL 14452900A IL 14452900 A IL14452900 A IL 14452900A IL 144529 A0 IL144529 A0 IL 144529A0
Authority
IL
Israel
Prior art keywords
augments
implantation rate
meiosis activating
activating sterol
sterol
Prior art date
Application number
IL14452900A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As, Schering Ag filed Critical Novo Nordisk As
Publication of IL144529A0 publication Critical patent/IL144529A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL14452900A 1999-02-26 2000-02-25 Meiosis activating sterol augments implantation rate IL144529A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900273 1999-02-26
PCT/DK2000/000080 WO2000052142A2 (en) 1999-02-26 2000-02-25 Culture medium comprising meiosis activating sterols (mas) and method for in vitro fertilisation

Publications (1)

Publication Number Publication Date
IL144529A0 true IL144529A0 (en) 2002-05-23

Family

ID=8091693

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14452900A IL144529A0 (en) 1999-02-26 2000-02-25 Meiosis activating sterol augments implantation rate

Country Status (16)

Country Link
US (2) US20020042927A1 (xx)
EP (1) EP1157096A2 (xx)
JP (1) JP2002537801A (xx)
KR (1) KR20020013505A (xx)
CN (1) CN1341147A (xx)
AU (1) AU2659200A (xx)
BR (1) BR0008536A (xx)
CA (1) CA2365225A1 (xx)
CZ (1) CZ20012671A3 (xx)
HU (1) HUP0200201A3 (xx)
IL (1) IL144529A0 (xx)
MX (1) MXPA01008657A (xx)
NO (1) NO20014120L (xx)
PL (1) PL350222A1 (xx)
WO (1) WO2000052142A2 (xx)
ZA (1) ZA200106101B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60023324T2 (de) * 1999-09-16 2006-07-20 Novo Nordisk A/S Zusammensetzung zur in-vitro befruchtung
AU3376501A (en) * 2000-02-25 2001-09-03 Novo Nordisk A/S Improvement of implantation rate
EP1257279A2 (en) * 2000-02-25 2002-11-20 Schering Aktiengesellschaft Improvement of implantation rate using ff-mas
JP2003533222A (ja) * 2000-05-18 2003-11-11 シエーリング アクチエンゲゼルシャフト 経年卵母細胞の受精
EP1216701A1 (en) * 2000-12-22 2002-06-26 Schering Aktiengesellschaft Process to increase the concentration of meiosis-activating sterols (MAS) in the cholesterol synthesis and the use of potent inhibitors in the process
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
CL2008003692A1 (es) * 2008-12-11 2011-05-13 Univ Pontificia Catolica Chile Fraccion de hormona foliculo estimulante (fsh) con un punto isoelectrico basico mayor a 4 y cadena de carbohidratos altamente ramificados y/o bisectadas; metodo de purificacion de dicha fraccion; composicion que comprende la fraccion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563059A (en) * 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
PL322106A1 (en) * 1995-03-06 1998-01-05 Novo Nordisk As Meiosis stimulation
ATE361091T1 (de) * 1999-02-24 2007-05-15 Novo Nordisk As Behandlung von unfruchtbarkeit
BR0008468A (pt) * 1999-02-24 2002-02-05 Novo Nordisk As Método para fertilização humana in vitro, uso de um hormÈnio hipotalânico e/ou hormÈnio pituitário ou de um agonista ou antagonista do mesmo ou de um derivado ativo do mesmo, kit farmacêutico em forma de dosagem única, e, qualquer novo aspecto ou combinação de aspectos
DE60023324T2 (de) * 1999-09-16 2006-07-20 Novo Nordisk A/S Zusammensetzung zur in-vitro befruchtung
US6544166B1 (en) * 1999-11-25 2003-04-08 Groendahl Christian Treatment of human infertility

Also Published As

Publication number Publication date
PL350222A1 (en) 2002-11-18
NO20014120L (no) 2001-10-25
WO2000052142A2 (en) 2000-09-08
WO2000052142A3 (en) 2001-03-22
EP1157096A2 (en) 2001-11-28
NO20014120D0 (no) 2001-08-24
CZ20012671A3 (cs) 2002-01-16
BR0008536A (pt) 2001-11-06
HUP0200201A2 (hu) 2002-05-29
JP2002537801A (ja) 2002-11-12
CA2365225A1 (en) 2000-09-08
CN1341147A (zh) 2002-03-20
AU2659200A (en) 2000-09-21
HUP0200201A3 (en) 2002-06-28
MXPA01008657A (es) 2003-06-24
KR20020013505A (ko) 2002-02-20
ZA200106101B (en) 2002-02-04
US20050175976A1 (en) 2005-08-11
US20020042927A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
AU2429401A (en) Implantable electro-acupuncture device
AU2001255522A1 (en) Mri-resistant implantable device
AU1618401A (en) Implantable device programmer
AU2492000A (en) Implantable neuro-stimulator
IL137294A0 (en) Antibodies against human cd40
GB9924959D0 (en) Implant alignment
EP1236452A4 (en) CONDOM
IL144529A0 (en) Meiosis activating sterol augments implantation rate
HUP0200274A2 (en) Fitting
TW554668U (en) Waist adjusting device
EP1194439A4 (en) EAG2 OF HUMAN ORIGIN
GB9916376D0 (en) Implant device
HUP0201655A2 (en) Opening-limiting fitting
AU1056201A (en) Snore suppressing device
GB9909005D0 (en) Control devices
GB9929631D0 (en) Implantable hearing aid
GB2349747B (en) Anti-radiation device
GB9920093D0 (en) Tiling aid
TW402926U (en) Closestool seat setting device
CA84163S (en) Penis stimulator
GB9909053D0 (en) Condom
GB9929117D0 (en) Visual aid
GB0010782D0 (en) Secure seat aid
GB9903468D0 (en) Sexual aid
GB9810740D0 (en) Treatment using implantable devices